Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/07/5901-5-13$7.00
Pharmacol Rev 59:5-13, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pin, J.-P.
Right arrow Articles by Spedding, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pin, J.-P.
Right arrow Articles by Spedding, M.

Article

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

Jean-Philippe Pin, Richard Neubig, Michel Bouvier, Lakshmi Devi, Marta Filizola, Jonathan A. Javitch, Martin J. Lohse, Graeme Milligan, Krzysztof Palczewski, Marc Parmentier and Michael Spedding

Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)

Abstract
I. Introduction
II. The Class C G Protein-Coupled Receptors
III. The Class A G Protein-Coupled Receptors
    A. Rhodopsin
    B. The Melatonin Receptor
    C. The Glycoprotein Hormone Receptors
    D. The Opioid Receptors
    E. The CCR2 and CCR5 Receptors
    F. The AT1 and Mas Receptors
    G. The alpha1B and alpha1D Adrenoceptors
    H. The beta1 and beta2 Adrenoceptors
IV. On the Nomenclature and Recognition of Multimeric G Protein-Coupled Receptors
Abstract

G protein-coupled receptors (GPCRs) have long been considered to be monomeric membrane proteins. Although numerous recent studies have indicated that GPCRs can form multimeric complexes, the functional and pharmacological consequences of this phenomenon have remained elusive. With the discovery that the functional GABAB receptor is an obligate heterodimer and with the use of energy transfer technologies, it is now accepted that GPCRs can form heteromultimers. In some cases, specific properties of such heteromers not shared by their respective homomers have been reported. Although in most cases these properties have only been observed in heterologous expression systems, there are a few reports describing data consistent with such heteromultimeric GPCR complexes also existing in native tissues. The present article illustrates well-documented examples of such native multimeric complexes, lists a number of recommendations for recognition and acceptance of such multimeric receptors, and gives recommendations for their nomenclature.


Address correspondence to: Jean-Philippe Pin, Institut de Génomique Fonctionnelle, 141, rue de la Cardonille, 34094 Montpellier cedex 5, France. E-mail: jppin{at}igf.cnrs.fr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Damian, S. Mary, A. Martin, J.-P. Pin, and J.-L. Baneres
G Protein Activation by the Leukotriene B4 Receptor Dimer: EVIDENCE FOR AN ABSENCE OF TRANS-ACTIVATION
J. Biol. Chem., July 25, 2008; 283(30): 21084 - 21092.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Y. Choi, J. Simon, K. W. K. Tsim, and E. A. Barnard
Constitutive and Agonist-induced Dimerizations of the P2Y1 Receptor: RELATIONSHIP TO INTERNALIZATION AND SCAFFOLDING
J. Biol. Chem., April 18, 2008; 283(16): 11050 - 11063.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L. Szidonya, M. Cserzo, and L. Hunyady
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions
J. Endocrinol., March 1, 2008; 196(3): 435 - 453.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics